Rossari Biotech Announces Q2 FY26 Results: Revenues at Rs. 586.1 Cr, up 18% YoY

Rossari Biotech Limited, a Specialty-Chemicals manufacturer, has announced its financial results for the quarter ended September 30, 2025. The company reported a 18% YoY increase in revenues to Rs. 586.1 crore. The EBITDA stood at Rs. 71.9 crore, up 9% YoY, and the PAT increased by 5% to Rs. 36.9 crore from Rs. 35.3 crore. The company's Home, Personal Care and Performance Chemicals (HPPC), Textile Speciality Chemicals (TSC), and Animal Health and Nutrition (AHN) businesses grew by 16%, 21%, and 29% respectively. Exports grew by 36% YoY in Q2 FY26 and 27% in H1 FY26. The company has commissioned an additional 20,000 MTPA capacity at its Dahej facility and is planning to invest in Rossari International Limited Company, a wholly owned subsidiary in Saudi Arabia.